Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
7687874 | TrAC Trends in Analytical Chemistry | 2018 | 56 Pages |
Abstract
The reference standards of impurities (IMPs) and degradation products (DPs) are required by pharmaceutical industry and quality testing laboratories the world over to comply with stringent thresholds prescribed in the compendial tests. In all the major pharmacopoeias, more and more monographs are currently being modified to include tests for IMPs and DPs. This review does a critical analysis of the whole situation with respect to development, supply, costs, etc. of reference standards of IMPs and DPs. It is found that significant differences exist not only regarding these aspects, but even the definitions, nomenclatures, types, instructions for use, storage, handling, etc. Typical suggestions have been put forth, which may prove handy to Pharmacopoeial Discussion Group and the pharmacopoeial agencies during harmonization exercise. The write-up also discusses difficulties faced by the users, recent developments and the trends.
Keywords
NATAEDQMAPICDERDRSMAHTLCNDACASCRSPDEDPSLC-MSGMPGHSDSCCOAUSFDAIPCMSDsMHRARRTiPRSODIUSPOSHANMTBVSIUPACICRSSDSICP-OESUSPCFDAAASPharmacopoeial standardsLOQBritish PharmacopoeiaUV-VisTGAWorking standardsPh. Eur.nuclear magnetic resonanceBpcIMPsInternational Union of Pure and Applied ChemistryUnited States Food and Drug AdministrationReference standardsCapillary electrophoresisUnited States PharmacopeiaNew drug applicationAbbreviated new drug applicationThermogravimetric analysisNMRQuality assuranceGood Manufacturing PracticeLOD یا Limit of detectionChemical Abstracts ServiceMedicines and Healthcare products Regulatory AgencyRelative retention timeWorld Health OrganizationFood and Drug AdministrationGlobally harmonized system of classification and labelling of chemicalsANDAFTIRUltraviolet–visible spectroscopyInductively coupled plasma-optical emission spectrometryAtomic absorption spectroscopyinductively coupled plasma-mass spectrometryLiquid chromatography-mass spectrometryMass spectrometryFourier transform infrared spectroscopyICP-MSEuropean PharmacopoeiaMAPPNational FormularyPermitted daily exposureInfraredlimit of detectionlimit of quantitationDegradation productsPdGCenter for Drug Evaluation and ResearchICHActive Pharmaceutical IngredientRelated substancesImpuritiesMaterial safety data sheetX-ray diffractionXRDDifferential scanning calorimetrythin layer chromatographyliquid chromatographyhigh performance liquid chromatographyHPLCGas chromatographyquality controlWHO
Related Topics
Physical Sciences and Engineering
Chemistry
Analytical Chemistry
Authors
Dilip Kumar Singh, Archana Sahu, Sanjay Kumar, Saranjit Singh,